Questions

1199. Deputy Ken O'Flynn asked the Minister for Health in the absence of a national data system, what mechanisms are used to track clinical outcomes, complications, or patient follow-up in respect of minors referred for gender-related healthcare. [33140/26]

1200. Deputy Ken O'Flynn asked the Minister for Health to identify the individual office or role within the HSE or Department that holds ultimate accountability for clinical governance decisions affecting minors in gender-related care pathways pending the finalisation of the national Model of Care. [33141/26]

1201. Deputy Ken O'Flynn asked the Minister for Health whether any formal risk assessment has been conducted regarding the continuation of gender-related referral pathways for minors in the absence of national audit systems, outcome tracking, or a completed Model of Care. [33142/26]

1202. Deputy Ken O'Flynn asked the Minister for Health the expected publication date of the HSE expert group report examining the implications of the final Cass Review; whether it will be published in full; and whether it will include recommendations for immediate changes to clinical practice. [33143/26]

1206. Deputy Ken O'Flynn asked the Minister for Health to specify which named office or individual currently holds ultimate clinical and governance accountability for gender-related assessment and referral pathways for minors in the absence of a completed national Model of Care. [33179/26]

1208. Deputy Ken O'Flynn asked the Minister for Health the reason no national audit or independent review has been conducted since 2020 into gender-related assessment and referral pathways for minors. [33181/26]

1213. Deputy Ken O'Flynn asked the Minister for Health to confirm whether any formal interim governance framework, directive, or protocol has been issued to clinicians governing gender-related assessment and referral of minors pending completion of the national model of care; and to provide details of same. [33187/26]

1216. Deputy Ken O'Flynn asked the Minister for Health to set out whether her Department has issued any direction, guidance, or policy requirement to the HSE in respect of the collection of national data on referrals, assessments, outcomes, and costs associated with gender-related healthcare pathways for minors; and the current status of any such initiative.; and if she will make a statement on the matter. [33190/26]

1217. Deputy Ken O'Flynn asked the Minister for Health to confirm whether any legal or policy framework currently governs consent, capacity assessment, and parental involvement in decisions relating to gender-related assessment and referral pathways for minors at national level; and to specify the source of such framework. [33191/26]

1219. Deputy Ken O'Flynn asked the Minister for Health to outline what measures are currently in place to ensure consistency of clinical practice across regions in respect of gender-related assessment and referral pathways for minors in the absence of a finalised national model of care. [33193/26]

1220. Deputy Ken O'Flynn asked the Minister for Health to confirm whether her Department has established a timeline, with defined milestones, for the implementation of a national data collection system, audit framework, and governance structure for gender-related healthcare services for minors; and if so, to provide details. [33194/26]

1221. Deputy Ken O'Flynn asked the Minister for Health whether any formal risk assessment was conducted prior to permitting ongoing gender-related assessment and referral pathways for minors in the absence of a completed national model of care, national dataset, or audit framework; and if she will provide details. [33200/26]

1222. Deputy Ken O'Flynn asked the Minister for Health who holds ultimate legal and clinical accountability for decisions made in respect of gender-related assessment and referral of minors in the absence of a designated national governance authority. [33201/26]

1225. Deputy Ken O'Flynn asked the Minister for Health whether any cost tracking mechanism exists for gender-related referrals or treatments involving minors, including under the Treatment Abroad Scheme. [33204/26]

2093. Deputy Ken O'Flynn asked the Minister for Health whether her Department has approved or mandated the establishment of a national dataset for the purposes of planning, governance, oversight and evaluation of gender identity healthcare services provided to children and adolescents within the public health system; if not, whether such a dataset will be introduced; and the timeframe for its implementation. [20261/2…

2094. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives any aggregated national data from the Health Service Executive regarding the number of children and adolescents referred to gender identity services each year; if so, the annual totals for each of the years 2018 to 2025; and if she will make a statement on the matter. [20262/26]

2095. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical audit, patient safety review or governance evaluation has been undertaken since 2020 in respect of gender identity services provided to children and adolescents within the public health system; if so, to provide the dates and scope of such reviews; and if she will make a statement on the matter. [20263/26]

2096. Deputy Ken O'Flynn asked the Minister for Health whether the Department has received the report of the expert group established by the Health Service Executive to consider the implications of the final Cass Review for gender healthcare services in Ireland; if so, the date on which the report was received; and whether she intends to publish the report. [20264/26]

2097. Deputy Ken O'Flynn asked the Minister for Health the formal national clinical governance framework that currently applies to gender identity healthcare services provided to minors pending completion of the updated national model of care; and the specific safeguarding standards required under that framework. [20265/26]

2098. Deputy Ken O'Flynn asked the Minister for Health whether her Department has issued any policy direction, guidance or instruction to the Health Service Executive following publication of the final Cass Review regarding the provision of gender identity healthcare services to children and adolescents in Ireland. [20266/26]

2100. Deputy Ken O'Flynn asked the Minister for Health the formal methodological framework used by her Department when evaluating international clinical guidance prior to incorporation into national healthcare policy; and whether such a methodology was applied in respect of international guidance on gender identity healthcare between 2018 and 2023. [20274/26]

2101. Deputy Ken O'Flynn asked the Minister for Health the date on which the Health Service Executive completed its review of the Cass Review; whether the completed review has been submitted to her Department; the date on which her Department received the document, if applicable; whether she intends to publish the review; and if publication is not intended, the reason the document will not be placed in the public dom…

2102. Deputy Ken O'Flynn asked the Minister for Health the terms of reference issued for the Health Service Executive review of the Cass Review; the names or professional roles of the clinical experts who conducted that review; the governance structure under which the work was undertaken; and whether the review included consideration of safeguarding and clinical risk factors affecting children and adolescents. [20289…

2103. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive review of the Cass Review identified any recommendations relating to safeguarding, diagnostic standards, risk mitigation, or clinical governance in the treatment of children and adolescents presenting with gender incongruence or dysphoria; and whether such recommendations are being incorporated into the developing Model of Car…

2104. Deputy Ken O'Flynn asked the Minister for Health the expected timeline for the completion and publication of the updated Model of Care for gender healthcare services being developed by the Health Service Executive; the stages remaining in that process; and whether the Model of Care will be subject to public or professional consultation before adoption. [20291/26]